Stress Hyperglycemia Drives the Risk of Hospitalization for Chest Pain in Patients With Ischemia and Nonobstructive Coronary Arteries (INOCA)

Hyperglycemia, Reduced Hematopoietic Stem Cells, and Outcome of COVID-19

(2022) Benedetta Maria Bonora et al.   DIABETES

The Impact of the Stress Hyperglycemia Ratio on Short-term and Long-term Poor Prognosis in Patients With Acute Coronary Syndrome: Insight From a Large Cohort Study in Asia

(2022) Jie Yang et al.   DIABETES CARE

Predictive value of the stress hyperglycemia ratio in patients with acute ST-segment elevation myocardial infarction: insights from a multi-center observational study

(2022) Wei Xu et al.   Cardiovascular Diabetology

Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry

(2022) Pasquale Paolisso et al.   Cardiovascular Diabetology

Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge

(2022) Alice Bonanni et al.   Journal of Clinical Medicine

Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic status

(2022) Sunetra Mondal et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Admission Blood Glucose and 2-Year Mortality After Acute Myocardial Infarction in Patients With Different Glucose Metabolism Status: A Prospective, Nationwide, and Multicenter Registry

(2022) Kongyong Cui et al.   Frontiers in Endocrinology

Prognostic impact of coronary microvascular dysfunction assessed by caIMR in overweight with chronic coronary syndrome patients

(2022) Cailin Feng et al.   Frontiers in Endocrinology

Ischemia with No Obstructive Arteries (INOCA): A review of the prevalence, diagnosis and management

(2022) Breanna Hansen et al.   CURRENT PROBLEMS IN CARDIOLOGY

In-Hospital Hyperglycemia Is Associated With Worse Outcomes in Patients Admitted With COVID-19

(2022) Angela Lombardi et al.   DIABETES CARE

Therapeutic concordance improves blood pressure control in patients with resistant hypertension

(2022) Valentina Trimarco et al.   PHARMACOLOGICAL RESEARCH

Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk

(2021) Scott Wilson et al.   Journal of Clinical Hypertension

Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus

(2021) Shuai Chen et al.   Cardiovascular Diabetology

Predictive value of stress hyperglycemia ratio for the occurrence of acute kidney injury in acute myocardial infarction patients with diabetes

(2021) Side Gao et al.   BMC Cardiovascular Disorders

Prognostic Links Between OCT-Delineated Coronary Morphologies and Coronary Functional Abnormalities in Patients With INOCA

(2021) Kensuke Nishimiya et al.   JACC-Cardiovascular Interventions

Functional and Economic Impact of INOCA and Influence of Coronary Microvascular Dysfunction

(2021) Christopher L. Schumann et al.   JACC-Cardiovascular Imaging

Natural History of Patients with Ischemia and No Obstructive Coronary Artery Disease: The CIAO-ISCHEMIA Study

(2021) Harmony R. Reynolds et al.   CIRCULATION

Hyperglycemia Drives Stent Restenosis in STEMI Patients

(2021) Pasquale Mone et al.   DIABETES CARE

Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia

(2021) Pasquale Mone et al.   Cells

COVID-19, Hyperglycemia, and New-Onset Diabetes

(2021) Kamlesh Khunti et al.   DIABETES CARE

Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19

(2021) Stefania L. Calvisi et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Heart failure in diabetes

(2021) Stanislovas S. Jankauskas et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Management of ischaemia with non-obstructive coronary arteries (INOCA)

(2021) John F Beltrame et al.   BMJ-British Medical Journal

Issues for the management of people with diabetes and COVID-19 in ICU

(2020) Antonio Ceriello et al.   Cardiovascular Diabetology

Genetics of adrenergic signaling drives coronary artery calcification

(2020) Jessica Gambardella et al.   ATHEROSCLEROSIS

Coronary microvascular dysfunction is associated with poor glycemic control amongst female diabetics with chest pain and non-obstructive coronary artery disease

(2019) Jaskanwal D. Sara et al.   Cardiovascular Diabetology

Pathophysiology and diagnosis of coronary microvascular dysfunction in ST-elevation myocardial infarction

(2019) Lara S F Konijnenberg et al.   CARDIOVASCULAR RESEARCH

Impact of Hyperglycemia on Long-Term Outcome in Patients With ST-Segment Elevation Myocardial Infarction

(2019) Takayuki Kojima et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ischemia and No Obstructive Coronary Artery Disease (INOCA): What Is the Risk?

(2018) Romana Herscovici et al.   Journal of the American Heart Association

Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies

(2015) Peter C. Austin et al.   STATISTICS IN MEDICINE

Hyperglycemia and Mortality Among Patients With Coronary Artery Disease

(2013) D. Ding et al.   DIABETES CARE

Coronary microvascular dysfunction: an update

(2013) F. Crea et al.   EUROPEAN HEART JOURNAL

Impact of Stress Hyperglycemia on Myocardial Salvage Following Successfully Recanalized Primary Acute Myocardial Infarction

(2012) Ikuko Teraguchi et al.   CIRCULATION JOURNAL

Glycemic Control and Cardiovascular Mortality in Hemodialysis Patients With Diabetes: A 6-Year Cohort Study

(2012) J. Ricks et al.   DIABETES

Association of stress hyperglycemia and atrial fibrillation in myocardial infarction

(2008) Goran P. Koracevic et al.   WIENER KLINISCHE WOCHENSCHRIFT